Radiofrequency Ablation Devices Market Size 2024-2028

The radiofrequency ablation devices market size is forecast to increase by USD 3.53 billion, at a CAGR of 10.03% between 2023 and 2028. The market is experiencing significant growth, driven by the increasing prevalence of chronic diseases and the expansion of the geriatric population. These factors have led to a higher demand for minimally invasive procedures, such as RFA, for treating various conditions. Additionally, the market is witnessing an increase in mergers and acquisitions (M&A) activity, as companies seek to expand their product portfolios and enhance their market presence. However, the high recurrence rate of some ailments post-RFA treatment poses a challenge to market growth. Despite this, the market is expected to continue expanding due to the advantages of RFA over traditional surgical procedures, including fewer complications, shorter hospital stays, and quicker recovery times.

 Request Free Sample

Market Segmentation

The market report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in "USD billion" for the period 2024-2028, as well as historical data from 2018 - 2022 for the following segments.

• Product Outlook
  • RF ablation consumables
  • RF ablation systems
  • RF ablation catheters

• Region Outlook
  • North America
    • The U.S.
    • Canada
  • Europe
    • U.K.
    • Germany
    • France
    • Rest of Europe
  • APAC
    • China
    • India
  • Middle East & Africa
    • Saudi Arabia
    • South Africa
    • Rest of the Middle East & Africa

By Product Insights

The RF ablation consumables segment is estimated to witness significant growth during the forecast period. The market is witnessing significant growth, particularly in the sectors of Cancer Care and Cardiology, driven by the increasing prevalence of chronic diseases, such as Atrial Fibrillation and Chronic Pain, in the senior population. Healthcare systems are increasingly adopting elective procedures and surgical therapies, including RF ablation, to manage these conditions and provide effective pain relief. RF ablation technology, which utilizes high-frequency electrical currents to create controlled lesions in abnormal tissue growths, is a minimally invasive treatment with a shorter patient recovery time and reduced complications risk compared to traditional surgical methods.

Get a glance at the market share of various regions Download the PDF Sample

The RF ablation consumables segment accounted for USD 1.88 billion in 2018. Major market players, such as AtriCure and Royal Philips, are innovating in this space by introducing image-guided techniques and advanced catheter systems, generators, and accessories. In oncology, RF ablation is used for the ablation of tumors and nerves, while in cardiology, it is used for the treatment of atrial fibrillation. The aging population and the resulting increase in healthcare expenditure are further fueling the growth of the RF ablation devices market. The market for RF ablation consumables, which includes disposable items such as canulas, needles, single-use probes, single-use electrodes, and RF probes, holds a major share due to their one-time use and the need for safety and infection control.

Regional Analysis

For more insights on the market share of various regions Download PDF Sample now!

North America is estimated to contribute 45% to the growth of the global market during the market forecast period. Technavio's analysts have elaborately explained the regional trends and drivers that shape the market during the forecast period.

Radiofrequency ablation (RFA) devices are gaining significant traction in Cancer Care and Cardiology, particularly in the management of Atrial Fibrillation and Chronic Diseases. The senior population and those requiring elective procedures are major consumers of these minimally invasive surgical therapies. RFA technology utilizes high-frequency electrical currents to create controlled lesions, targeting specific tissues such as abnormal tissue growths, tumors, and nerves. Image-guided techniques enhance the precision and safety of these procedures. The prevalence of chronic diseases, including cancer and cardiovascular diseases, in the aging population has fueled the growth of this market. Healthcare systems are increasingly investing in RFA devices for pain management, oncology, and cardiology applications. Key players in this market include AtriCure, Royal Philips, and others. Their offerings include catheter systems, generators, and accessories. Healthcare expenditure on RFA devices is expected to rise due to the benefits of minimally invasive treatments, shorter patient recovery time, and improved treatment outcomes. However, there is a risk of complications, including pain relief and drug administration, which need to be carefully managed. The future of RFA technology lies in its ability to miniaturize, making it more accessible and cost-effective for healthcare providers and patients.

Market Dynamics

Radiofrequency ablation devices market refers to the segment of the healthcare industry focused on the production and sale of devices used in the ablation of abnormal tissue growths, primarily in the context of Cancer Care and Atrial Fibrillation treatment. These devices employ high-frequency electrical currents and medical technologies to create controlled lesions, making them an essential tool in Chronic Disease management, particularly for the growing senior population. The market for radiofrequency ablation devices is driven by the increasing prevalence of chronic diseases and the rising demand for elective procedures and surgical therapies. The market is witnessing strategic initiatives such as the development of advanced catheter systems, generators, and accessories, including ImageGuided Technique and Tissue Engagement Viewer, to enhance the efficacy and safety of these minimally invasive treatments. The market growth is further fueled by the increasing geriatric population and rising healthcare expenditure. In oncology, radiofrequency ablation devices are used for the ablation of tumors, making them an essential tool in cancer care. Overall, the radiofrequency ablation devices market is poised for significant growth in the coming years. Our researchers analyzed the data with 2023 as the base year, along with the key drivers, trends, and challenges. A holistic analysis of drivers will help companies refine their marketing strategies to gain a competitive advantage.

Key Market Driver

The increasing prevalence of chronic diseases and growth of geriatric population is notably driving market growth. The prevalence of chronic diseases, particularly among the aging demographic, is on the rise due to increasing mortality rates and sedentary lifestyles. According to the Centers for Disease Control and Prevention (CDC), approximately 15% of adults in the US had at least two chronic medical conditions in 2021. This number is projected to increase as the baby boomer population ages, with the CDC estimating that 12.1 million Americans will have atrial fibrillation alone by 2030. Chronic diseases encompass various conditions, including cardiovascular disorders such as cardiac arrhythmias like atrial fibrillation and ventricular tachycardia, gynecological disorders, diabetes, and cancer. Advanced medical imaging techniques, such as ultrasound, CT scans, and MRI, enable real-time visualization during treatment modalities like microwave ablation and cryoablation. Flexible catheters, RF generators, and consumables are essential components of these ablation procedures. In addition, these minimally invasive procedures are increasingly being performed in ambulatory surgical centers and are gaining popularity in cosmetic surgery, gynecology, and urology. The use of cardiac mapping and navigation platforms further enhances the precision and efficacy of these procedures. Thus, such factors are driving the growth of the market during the forecast period.

Significant Market Trends

The increasing M&A activity is the key trend in the market. Radiofrequency ablation devices are utilized in various treatment modalities for chronic diseases, including cardiovascular disorders and gynecological conditions. These devices employ flexible catheters for precise navigation and manufacturing, often in conjunction with advanced medical imaging techniques such as ultrasound, CT scans, Cannulas, and MRI for real-time visualization. Microwave ablation and cryoablation are alternative ablation techniques used in place of radiofrequency ablation. The global market for radiofrequency ablation devices is witnessing significant growth due to the increasing prevalence of chronic diseases, aging demographics, and the expansion of ambulatory surgical centers. Vendors are enhancing their product offerings through mergers and acquisitions, enabling product differentiation and expansion. For instance, Medtronic's USD925 million acquisition of Affera in January 2022 aimed to penetrate the advanced cardiac mapping market, which uses Affera's detailed heart mapping catheters for guiding pulsed-field and radiofrequency ablation procedures. These catheters apply thermal or electrical energy to scar cardiac tissues, treating conditions such as atrial fibrillation, ventricular tachycardia, and cardiac arrhythmias by blocking abnormal signals within the heart. In addition, radiofrequency ablation devices are employed in cosmetic surgery, urology, and gynecology applications. Thus, such trends will shape the growth of the market during the forecast period.

Major Market Challenge

The high recurrence rate of some ailments post-RFA treatment is the major challenge that affects the growth of the market. Radiofrequency ablation (RFA) devices have gained significant attention in the medical community due to their effectiveness in treating various chronic diseases, including cardiovascular disorders such as cardiac arrhythmias, and gynecological disorders. Advanced medical imaging techniques, such as ultrasound, CT scans, and MRI, enable real-time visualization during the procedure for precise treatment. Flexible catheters, used in RFA procedures, allow for the delivery of heat or cold energy to targeted areas for microwave ablation or cryoablation. Despite the advantages, patients may be deterred from undergoing RFA treatment due to the high recurrence rate. This can result in increased costs for patients and healthcare providers, particularly for those with limited financial resources. The recurrence rate can also limit the effectiveness of RFA as a treatment option, potentially leading to a shift towards alternative treatments. This can negatively impact the demand for RFA devices. Moreover, the high recurrence rate can hinder research and development efforts in the field of RFA. RF generators and consumables are essential components of RFA devices, and their market growth is influenced by the prevalence of chronic diseases, such as Chronic Wound Care, cardiac arrhythmias, atrial fibrillation, and ventricular tachycardia. The aging demographics and the increasing number of ambulatory surgical centers also contribute to the market growth. Hence, the above factors will impede the growth of the market during the forecast period.

Exclusive Customer Landscape

The market forecasting report includes the adoption lifecycle of the market, covering from the innovator's stage to the laggard's stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their market growth analysis strategies.

 Customer Landscape

Key Companies & Market Insights

Companies are implementing various strategies, such as strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market.

Abbott Laboratories - The company offers radiofrequency ablation device named as Simplicity Probe, a self contained, multi electrode radiofrequency, patented SI denervation solution, it features three independent active areas to generally reduce procedure time.

The market research and growth report also includes detailed analyses of the competitive landscape of the market and information about key companies, including:

• Abbott Laboratories
• AngioDynamics Inc.
• Arthrex Inc.
• AtriCure Inc.
• Avanos Medical Inc.
• BIOTRONIK SE and Co. KG
• Bramsys Industria e Comercio Ltda.
• Conmed Corp.
• Epimed International Inc.
• F Care Systems NV
• Hologic Inc.
• Johnson and Johnson Services Inc.
• Koninklijke Philips N.V.
• Medtronic Plc
• Merit Medical Systems Inc.
• OSYPKA AG
• RF Medical Co. Ltd.
• Smith and Nephew plc
• Stryker Corp.
• Venclose Inc.

Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.

Market Analyst Overview

The market is a significant segment in the healthcare industry, focusing on minimally invasive treatments for various chronic diseases and conditions. These devices use high-frequency electrical currents to create controlled lesions in target specific tissues, effectively treating abnormal tissue growths, tumors, nerves, and other abnormalities. Key applications include cancer care, atrial fibrillation, chronic diseases, and pain management. The senior population, with its increasing prevalence due to the aging population and healthcare expenditure, is a significant end-user. The market growth is driven by the rising prevalence of chronic diseases such as cancer, cardiovascular diseases, and chronic pain. The use of Image guided technique and minimally invasive treatments offers benefits like reduced patient recovery time and lower complications risk. RF ablation technology is increasingly being used in oncology, cardiology, and pain management, making it a promising area for innovation and development. The market is expected to grow significantly due to the increasing demand for effective and less invasive treatments for various conditions. However, there are challenges such as the risk of complications and treatment outcomes that need to be addressed to ensure the safety and efficacy of RF ablation devices. The miniaturization of these devices is also a key trend, making them more accessible and convenient for healthcare systems and patients.

Download PDF Sample

What are the Key Data Covered in this Market Research Report?

• CAGR of the market during the forecast period
• Detailed information on factors that will drive the market growth and forecasting between 2024 and 2028
• Precise estimation of the size of the market  and its contribution of the market in focus to the parent market
• Accurate predictions about upcoming market growth and trends and changes in consumer behaviour
• Growth of the market across North America, Europe, Asia, and Rest of World (ROW)
• Thorough analysis of the market's competitive landscape and detailed information about companies
• Comprehensive analysis of factors that will challenge the growth of market companies

We can help! Our analysts can customize this market research report to meet your requirements. Get in touch